These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 30054781)

  • 21. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure.
    Salvador DR; Rey NR; Ramos GC; Punzalan FE
    Cochrane Database Syst Rev; 2004; (1):CD003178. PubMed ID: 14974008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous Infusion Versus Intermittent Boluses of Furosemide in Acute Heart Failure: A Systematic Review and Meta-Analysis.
    Chan JSK; Kot TKM; Ng M; Harky A
    J Card Fail; 2020 Sep; 26(9):786-793. PubMed ID: 31730917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous Infusion versus Intermittent Bolus Injection of Furosemide in Critically Ill Patients: A Systematic Review and Meta-analysis.
    Ng KT; Velayit A; Khoo DKY; Mohd Ismail A; Mansor M
    J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2303-2310. PubMed ID: 29454528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of intermittent vs continuous furosemide for heart failure concomitant renal dysfunction: A protocol for systematic review and meta-analysis.
    Chen S; Lin Y; Zhou M; Zhou C
    Medicine (Baltimore); 2021 Apr; 100(16):e25669. PubMed ID: 33879751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.
    Aziz EF; Alviar CL; Herzog E; Cordova JP; Bastawrose JH; Pamidimukala CK; Tojino A; Park TS; Musat D; Kukin M
    Hellenic J Cardiol; 2011; 52(3):227-35. PubMed ID: 21642071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry.
    Peacock WF; Costanzo MR; De Marco T; Lopatin M; Wynne J; Mills RM; Emerman CL;
    Cardiology; 2009; 113(1):12-9. PubMed ID: 18931492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
    de Denus S; Rouleau JL; Mann DL; Huggins GS; Cappola TP; Shah SH; Keleti J; Zada YF; Provost S; Bardhadi A; Phillips MS; Normand V; Mongrain I; Dubé MP
    Pharmacogenomics J; 2017 Mar; 17(2):192-200. PubMed ID: 26927285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diuretic dosing in acute decompensated heart failure: lessons from DOSE.
    Campbell PT; Ryan J
    Curr Heart Fail Rep; 2012 Sep; 9(3):260-5. PubMed ID: 22699924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial.
    Llorens P; Miró Ò; Herrero P; Martín-Sánchez FJ; Jacob J; Valero A; Alonso H; Pérez-Durá MJ; Noval A; Gil-Román JJ; Zapater P; Llanos L; Gil V; Perelló R
    Emerg Med J; 2014 Sep; 31(9):706-13. PubMed ID: 23793945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF.
    Palazzuoli A; Ruocco G; Vescovo G; Valle R; Di Somma S; Nuti R
    ESC Heart Fail; 2017 Nov; 4(4):479-486. PubMed ID: 28980452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial.
    Rohde LE; Rover MM; Figueiredo Neto JA; Danzmann LC; Bertoldi EG; Simões MV; Silvestre OM; Ribeiro ALP; Moura LZ; Beck-da-Silva L; Prado D; Sant'Anna RT; Bridi LH; Zimerman A; Raupp da Rosa P; Biolo A
    Eur Heart J; 2019 Nov; 40(44):3605-3612. PubMed ID: 31424503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous Infusion Versus Bolus Injection of Loop Diuretics for Patients With Congestive Heart Failure: A Meta-Analysis.
    Karedath J; Asif A; Tentu N; Zahra T; Batool S; Sathish M; Sandhu QI; Khan A
    Cureus; 2023 Feb; 15(2):e34758. PubMed ID: 36909062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous infusion or bolus injection of loop diuretics for congestive heart failure?
    Zepeda P; Rain C; Sepúlveda P
    Medwave; 2016 Apr; 16 Suppl 2():e6426. PubMed ID: 27145033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of three diuretic treatment strategies for patients with acute decompensated heart failure.
    Yayla Ç; Akyel A; Canpolat U; Gayretli Yayla K; Eyiol A; Akboğa MK; Türkoğlu S; Tavil Y; Boyacı B; Çengel A
    Herz; 2015 Dec; 40(8):1115-20. PubMed ID: 26135463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypochloremia and Diuretic Resistance in Heart Failure: Mechanistic Insights.
    Hanberg JS; Rao V; Ter Maaten JM; Laur O; Brisco MA; Perry Wilson F; Grodin JL; Assefa M; Samuel Broughton J; Planavsky NJ; Ahmad T; Bellumkonda L; Tang WH; Parikh CR; Testani JM
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27507113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis.
    Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM
    J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Furosemide Versus Torsemide on Hospitalizations and Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Controlled Trials.
    Singh S; Goel S; Duhan S; Chaudhary R; Garg A; Tantry US; Gurbel PA
    Am J Cardiol; 2023 Nov; 206():42-48. PubMed ID: 37677884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study.
    Rahhal A; Saad MO; Tawengi K; Assi AAR; Habra M; Ahmed D
    BMC Cardiovasc Disord; 2019 May; 19(1):127. PubMed ID: 31138146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.
    Balsam P; Ozierański K; Tymińska A; Główczyńska R; Peller M; Fojt A; Cacko A; Sieradzki B; Bakuła E; Markulis M; Kowalik R; Huczek Z; Filipiak KJ; Opolski G; Grabowski M
    Trials; 2017 Jan; 18(1):36. PubMed ID: 28114980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
    Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
    JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.